首页> 外文期刊>Annals of epidemiology >Hospitalized congestive heart failure after renal transplantation in the United States.
【24h】

Hospitalized congestive heart failure after renal transplantation in the United States.

机译:在美国,肾移植术后住院的充血性心力衰竭。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: African Americans have increased risk for congestive heart failure (CHF) compared to Caucasians in the general population, but the risk of CHF in African American renal transplant recipients has not been studied in a national renal transplant population. METHODS: Therefore, 33,479 renal transplant recipients in the United States Renal Data System (USRDS) from 1 July, 1994 to 30 June, 1997 were analyzed in an historical cohort study of the incidence, associated factors, and mortality of hospitalizations with a primary discharge diagnosis of CHF [International Classification of Diseases-9 (ICD9) Code 428.x]. RESULTS: African American renal transplant recipients had increased age-adjusted risk of hospitalizations for congestive heart failure compared to African Americans in the general population [rate ratio 4.60, 95% confidence interval (CI) 4.59-4.62]. In logistic regression analysis, African American recipients had increased risk of congestive heart failure after renal transplantation, independent of other factors. Among other significant factors associated with congestive heart failure, the strongest were graft loss and allograft rejection. No maintenance immunosuppressive medications were associated with CHF. In Cox regression analysis patients hospitalized for CHF had increased all-cause mortality compared with all other recipients (hazard ratio 3.69, 95% CI, 2.23-6.10), but African American recipients with CHF were not at significantly increased risk of mortality compared to Caucasian recipients with CHF. CONCLUSIONS: African Americans recipients were at high risk for CHF after transplant independent of other factors. The reasons for this increased risk should be the subject of further study. All potential transplant recipients should receive particular attention for the diagnosis and prevention of CHF in the transplant evaluation process, which includes preservation of allograft function.
机译:目的:与普通人群相比,非裔美国人的充血性心力衰竭(CHF)风险增加,但尚未在全国性肾脏移植人群中研究非裔美国人肾移植接受者的CHF风险。方法:因此,对1994年7月1日至1997年6月30日美国肾脏数据系统(USRDS)中33,479名肾移植受者进行了一项历史队列研究,分析了原发性出院的发生率,相关因素和死亡率CHF的诊断[国际疾病分类9(ICD9)代码428.x]。结果:与一般人群中的非裔美国人相比,非裔美国人肾移植接受者的年龄校正后的充血性心力衰竭住院风险增加[比率4.60,95%置信区间(CI)4.59-4.62]。在逻辑回归分析中,非裔美国人接受肾移植后充血性心力衰竭的风险增加,与其他因素无关。在与充血性心力衰竭相关的其他重要因素中,最严重的是移植物丢失和同种异体移植排斥。没有维持性免疫抑制药物与CHF相关。在Cox回归分析中,与其他所有接受者相比,因CHF住院的患者的全因死亡率增加了(危险比3.69、95%CI,2.23-6.10),但是与白种人相比,非洲裔美国人接受CHF的死亡率没有显着增加瑞士法郎的收件人。结论:非裔美国人接受移植后发生CHF的风险较高,与其他因素无关。风险增加的原因应进一步研究。在移植评估过程中,所有潜在的移植接受者应特别注意CHF的诊断和预防,包括保留同种异体移植功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号